Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
104
-
Total shares
-
20.6M
-
Shares change
-
+541K
-
Total reported value, excl. options
-
$397M
-
Value change
-
+$12M
-
Number of buys
-
49
-
Number of sells
-
-45
-
Price
-
$19.24
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2018
103 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2018.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.6M shares
of 50.5M outstanding shares and own 40.86% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.99M shares), Vanguard Group Inc (2.24M shares), DIMENSIONAL FUND ADVISORS LP (1.91M shares), FEDERATED INVESTORS INC /PA/ (1.28M shares), STATE STREET CORP (1.05M shares), TEACHERS ADVISORS, LLC (567K shares), Invesco Ltd. (505K shares), NORTHERN TRUST CORP (480K shares), Bank of New York Mellon Corp (419K shares), and GEODE CAPITAL MANAGEMENT, LLC (389K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.